AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
AFTER THE CLOSE.(TO THE POINT)
LUCENT expects to raise $1 billion via a private offering of redeemable convertible preferred stock. Earlier on Tuesday, S&P again cut the ailing telecom gear maker's debt ratings.
RENAL CARE met second-quarter views of 37 cents a share, up 12%. The dialysis provider sees profit rising 15% for the rest of the year and the next two to four years.
MENTOR earned 42 cents a share in its first quarter, up 24% and 3 cents above views. The medical and dental supplier's sales climbed 20% to $81 million.
KLA-TENCOR'S fourth-quarter profit tumbled 38% to 29 cents. But that beat goals by 3 cents. The chip gear maker's sales slid 4%.
...- Abbott Gets European OK for Kaletra and Vertex, J&J Forge $545 Million...
- Press release article from: M2 Presswire July 4, 2006 700+ words
M2 PRESSWIRE-4 July 2006-U.S. Equity News: Abbott Gets European OK for Kaletra and Vertex, J&J Forge $545 Million Hepatitis C Deal(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:05072006...
- Allergan Announces Quarterly Conference Call and Guidant: European OK on Stent...
- Press release article from: M2 Presswire January 25, 2006 700+ words
M2 PRESSWIRE-25 January 2006-US Financial Network: Allergan Announces Quarterly Conference Call and Guidant: European OK on Stent Imminent(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:25012006 City of Industry, CA - Medical Devices industry...
- INCONTROL GETS EUROPEAN OK TO MARKET ITS TADPOLE.(Business)
- Newspaper article from: Seattle Post-Intelligencer (Seattle, WA) June 10, 1997 700+ words
InControl Inc. of Redmond has received authorization to sell its temporary arterial defibrillation system, called TADPole, in member countries of the European Union. The company received permission to place the ``CE Mark'' on the product, indicating it conforms to the standards of the European
- BRIEFCASE TWO AMGEN DRUGS NEAR EUROPEAN OK.(Business)
- Newspaper article from: Daily News (Los Angeles, CA) July 31, 2004 700+ words
Byline: - Staff and Wire Services THOUSAND OAKS - Biotechnology giant Amgen Inc. said Friday that the company is a step closer to receiving approval in Europe to market Enbrel and Mimpara for the treatment of skin and kidney conditions. Enbrel treats moderate to severe psoriasis, while Mimpara
- DUPONT, KOCH DEAL GETS EUROPEAN OK.(Brief Article)
- Magazine article from: WWD January 22, 2004 700+ words
NEW YORK -- DuPont and Koch Industries got a thumbs-up Wednesday from European regulators to go ahead with the sale of DuPont's Invista textiles unit. A statement from the European Commission said, "The combined market shares would not be very high at European or worldwide level. The transaction
- RELIANT CUTS REVENUES BECAUSE OF SHAM TRADES.(Business)
- Newspaper article from: Seattle Post-Intelligencer (Seattle, WA) May 22, 2002 700+ words
...sales. Staples earned 20 cents per share, up from $40 million, or 9 cents per share, in the year...charge of $29 million, or 6 cents per share. Arthur Andersen...Stronger Airbus cockpit doors get European OK BLAGNAC, France - Aviation...
- The Boston Globe Business Briefs Column.
- Newspaper article from: Knight Ridder/Tribune Business News May 19, 2004 700+ words
...stent market about evenly. --Ross Kerber BIOGEN TO SEEK EUROPEAN OK FOR DRUG: Biogen Idec Inc. said it would seek European approval...results Monday after the close of trading; its shares rose 93 cents to $14.49 in Nasdaq trading on Tuesday. Last year, the...
- Gasoline prices up 0.97 cent in week.
- Newspaper article from: The Oil Daily Hahn, Susan L. April 17, 1985 700+ words
...price rose 0.94 cent per gallon to 85.37 cents, which is about...April 13 by 2.0 cents per gallon in Burleigh, Idaho; 1.0 cent in Tampa, Fla...Toledo, Ohio; 1.0 cent for regular leaded...unleaded, and 1.5 cents for super unleaded...
